CAROTID ATHEROSCLEROSIS
Clinical trials for CAROTID ATHEROSCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new CAROTID ATHEROSCLEROSIS trials appear
Sign up with your email to follow new studies for CAROTID ATHEROSCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a green tea compound prevent second heart attacks?
Disease control OngoingThis trial tests whether a dietary supplement called Tertinat, containing epigallocatechin-3-gallate, can reduce major heart problems in people with atherosclerosis who have recently had bypass or stent surgery. Over two years, participants take either the supplement or a placebo…
Matched conditions: CAROTID ATHEROSCLEROSIS
Phase: PHASE2 • Sponsor: Institute for Atherosclerosis Research, Russia • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Your gut bugs could predict your stroke risk
Knowledge-focused OngoingThis study looks at whether bacteria in the gut and mouth are linked to a higher risk of stroke in people with narrowed neck arteries. Researchers will measure certain waste products from these bacteria in the blood and see if they relate to stroke or worsening artery blockages. …
Matched conditions: CAROTID ATHEROSCLEROSIS
Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Could a new ultrasound score prevent strokes? 855-Patient study launches
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests a new way to grade carotid plaques using ultrasound, called Plaque-RADS, to see if it can predict stroke risk better than current methods. Researchers will collect data from 855 people with asymptomatic carotid plaques, both from past records and new patients. Th…
Matched conditions: CAROTID ATHEROSCLEROSIS
Sponsor: Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Heart drug study cancelled before it began
Knowledge-focused TerminatedThis study was designed to see if a cholesterol-lowering drug called a PCSK9 inhibitor could also reduce inflammation in the arteries of people with heart disease. Researchers planned to use a special imaging scan to measure inflammation. The study was withdrawn before enrolling …
Matched conditions: CAROTID ATHEROSCLEROSIS
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC